Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20,956 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently.
Kim HS, Kim BR, Dao TTP, Kim JM, Kim YJ, Son H, Jo S, Kim D, Kim J, Suh YJ, Kim HJ, Cho BS, Park S. Kim HS, et al. Among authors: kim br, kim yj, kim hj, kim jm, kim d, kim j. Blood Adv. 2023 Jul 11;7(13):3155-3168. doi: 10.1182/bloodadvances.2022007956. Blood Adv. 2023. PMID: 36809797 Free PMC article.
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
Cho BS, Kim YJ, Cho SG, Kim SY, Eom KS, Kim HJ, Lee S, Min CK, Kim DW, Lee JW, Min WS, Kim CC. Cho BS, et al. Among authors: kim cc, kim yj, kim hj, kim dw, kim sy. Int J Hematol. 2007 Jun;85(5):446-55. doi: 10.1532/IJH97.A30616. Int J Hematol. 2007. PMID: 17562624 Clinical Trial.
Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
Kim SY, Lee JW, Lim J, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Kim CC. Kim SY, et al. Among authors: kim cc, kim yj, kim hj, kim dw. Biol Blood Marrow Transplant. 2007 Jul;13(7):863-70. doi: 10.1016/j.bbmt.2007.03.013. Epub 2007 May 24. Biol Blood Marrow Transplant. 2007. PMID: 17580265 Free article. Clinical Trial.
Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Lee S, et al. Among authors: kim cc, kim yj, kim hj, kim dw, kim sy. Biol Blood Marrow Transplant. 2007 Sep;13(9):1083-94. doi: 10.1016/j.bbmt.2007.06.001. Epub 2007 Jul 20. Biol Blood Marrow Transplant. 2007. PMID: 17697971 Free article.
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older.
Eom KS, Kim HJ, Min WS, Lee S, Min CK, Cho BS, Kim SY, Kim YJ, Lee DG, Choi SM, Cho SG, Kim DW, Lee JW, Shin WS, Kim CC. Eom KS, et al. Among authors: kim cc, kim yj, kim hj, kim dw, kim sy. Eur J Haematol. 2007 Nov;79(5):398-404. doi: 10.1111/j.1600-0609.2007.00946.x. Epub 2007 Oct 4. Eur J Haematol. 2007. PMID: 17916082 Clinical Trial.
The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ, Choi Y, Min WS, Kim TG, Cho BS, Kim SY, Eom KS, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Kim CC. Kim HJ, et al. Among authors: kim cc, kim tg, kim dw, kim sy. Transplantation. 2007 Nov 15;84(9):1082-91. doi: 10.1097/01.tp.0000285918.72930.35. Transplantation. 2007. PMID: 17998861
Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC. Kim HJ, et al. Among authors: kim cc, kim yj. Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. doi: 10.1016/j.bbmt.2009.02.010. Epub 2009 Apr 9. Biol Blood Marrow Transplant. 2009. PMID: 19450755 Free article.
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.
Cho BS, Min CK, Kim HJ, Lee S, Kim YJ, Lim JY, Jeong DC, Cho B, Kim HK, Eom KS, Cho SG, Kim DW, Lee JW, Min WS, Kim CC, Chung NG. Cho BS, et al. Among authors: kim cc, kim yj, kim hj, kim hk, kim dw. Biol Blood Marrow Transplant. 2010 May;16(5):629-38. doi: 10.1016/j.bbmt.2009.11.023. Epub 2009 Dec 4. Biol Blood Marrow Transplant. 2010. PMID: 19963070 Free article.
20,956 results
You have reached the last available page of results. Please see the User Guide for more information.